NEPHROS INC
Qualité des données : 100%
NEPH
Nasdaq
Manufacturing
Measuring & Analyzing Instruments
2,96 €
▲
0,05 €
(1,72%)
Cap. Boursière: 31,51 M
Prix
2,96 €
Cap. Boursière
31,51 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—
Quick Summary
Points Clés
Revenue grew 15,92% annually over 5 years — strong growth
Earnings grew 1513,51% over the past year
ROE of 12,18% — decent returns on equity
Generating 1,59 M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 16,75%
Cash machine — converts 133,17% of earnings into free cash flow
Croissance
Revenue Growth (5Y)
15,92%
Au-dessus de la moyenne du secteur (1,82%)
Revenue (1Y)32,67%
Earnings (1Y)1513,51%
FCF Growth (3Y)45,41%
Qualité
Return on Equity
12,18%
Au-dessus de la moyenne du secteur (-53,34%)
ROIC10,68%
Net Margin6,35%
Op. Margin6,10%
Sécurité
Debt / Equity
N/A
Current Ratio4,34
Interest Coverage1146,00
Valorisation
PE (TTM|NTM|2027)
26,39 | 22,77 | 22,77
Au-dessus de la moyenne du secteur (-1,47)
P/B Ratio3,15
EV/EBITDA20,48
Dividend YieldN/A
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1364 pairs)
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1364 pairs)| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 26,4 | -1,5 |
| P/B | 3,2 | 1,6 |
| ROE % | 12,2 | -53,3 |
| Net Margin % | 6,4 | -41,5 |
| Rev Growth 5Y % | 15,9 | 1,8 |
| D/E | — | 0,3 |
Objectif de Cours des Analystes
2 analystes
Strong Buy
Actuel
2,96 €
Objectif
7,00 €
6,00 €
7,00 €
8,00 €
Prévisions
P/E Prévisionnel
22,77
BPA Prévisionnel
0,13 €
Croissance BPA (est.)
+116,7%
CA Est.
22,86 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2027 |
0,13 €
0,13 € – 0,13 €
|
22,86 M | 1 |
| FY2026 |
0,06 €
0,06 € – 0,06 €
|
20,47 M | 2 |
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| 2026 Q2 |
0,00 €
0,00 € – 0,00 €
|
4,80 M | 2 |
| 2026 Q1 |
0,01 €
0,01 € – 0,01 €
|
4,99 M | 2 |
Surprises de Résultats
Derniers 4 trimestres
| Trimestre | BPA Est. | BPA Réel | Surprise |
|---|---|---|---|
| Q42025 | 0,01 € | 0,01 € | 0,0% |
| Q32025 | -0,02 € | 0,03 € | +250,0% |
| Q22025 | -0,03 € | 0,02 € | +180,0% |
| Q12025 | -0,01 € | 0,05 € | +1100,0% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 32,67% | Revenue Growth (3Y) | 14,88% |
| Earnings Growth (1Y) | 1513,51% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 15,92% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 18,79 M | Net Income (TTM) | 1,19 M |
| ROE | 12,18% | ROA | 9,37% |
| Gross Margin | 61,87% | Operating Margin | 6,10% |
| Net Margin | 6,35% | Free Cash Flow (TTM) | 1,59 M |
| ROIC | 10,68% | FCF Growth (3Y) | 45,41% |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 4,34 |
| Interest Coverage | 1146,00 | Asset Turnover | 1,47 |
| Working Capital | 8,24 M | Tangible Book Value | 8,92 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 26,39 | Forward P/E | 22,77 |
| P/B Ratio | 3,15 | P/S Ratio | 1,68 |
| PEG Ratio | N/A | Forward PEG | 0,20 |
| EV/EBITDA | 20,48 | Fwd EV/EBITDA | N/A |
| Forward P/S | 1,38 | Fwd Earnings Yield | 4,39% |
| FCF Yield | 5,05% | ||
| Market Cap | 31,51 M | Enterprise Value | 26,34 M |
| Per Share | |||
| EPS (Diluted TTM) | 0,11 | Revenue / Share | 1,77 |
| FCF / Share | 0,15 | OCF / Share | 0,15 |
| EPS CAGR (1Y) | 1000,00% | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 0,29% | FCF Conversion | 133,17% |
| SBC-Adj. FCF | 1,31 M | Growth Momentum | 16,75 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 18,79 M | 14,16 M | 14,24 M | 9,98 M | 10,40 M |
| Net Income | 1,19 M | 74 000,0 | -1,58 M | -7,11 M | -3,87 M |
| EPS (Diluted) | 0,11 | 0,01 | -0,15 | — | — |
| Gross Profit | 11,63 M | 8,72 M | 8,41 M | 4,73 M | 5,74 M |
| Operating Income | 1,15 M | 6 000,0 | -1,59 M | -4,34 M | -4,34 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 1,34 M | 906 000,0 | 873 000,0 | 1,26 M | 2,17 M |
| SG&A Expenses | 9,00 M | 7,68 M | 8,91 M | 7,59 M | 7,71 M |
| D&A | 140 000,0 | 135 000,0 | 214 000,0 | 218 000,0 | 202 000,0 |
| Interest Expense | 1 000,0 | 1 000,0 | 2 000,0 | 20 000,0 | 41 000,0 |
| Income Tax | 12 000,0 | 15 000,0 | 0,0 | 0,0 | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 13,64 M | 11,21 M | 11,86 M | 11,00 M | 17,65 M |
| Total Liabilities | 3,44 M | 2,63 M | 3,50 M | 2,12 M | 2,90 M |
| Shareholders' Equity | 10,20 M | 8,59 M | 8,36 M | 5,59 M | 11,70 M |
| Total Debt | — | — | — | 71 000,0 | 343 000,0 |
| Cash & Equivalents | 5,40 M | 3,76 M | 4,31 M | 3,63 M | 6,97 M |
| Current Assets | 11,22 M | 8,30 M | 8,41 M | 8,26 M | 13,63 M |
| Current Liabilities | 2,77 M | 1,56 M | 2,11 M | 1,41 M | 2,39 M |
{"event":"ticker_viewed","properties":{"ticker":"NEPH","listing_kind":"stock","pathname":"/stocks/neph","exchange":"Nasdaq","country":"US"}}